Select Medical (SEM) Projected to Post Quarterly Earnings on Thursday

Select Medical (NYSE:SEM) is projected to release its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Select Medical to post earnings of $0.17 per share and revenue of $1.3298 billion for the quarter. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS.Interested persons can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Friday, October 31, 2025 at 9:00 AM ET.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, July 31st. The health services provider reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.04. The firm had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.35 billion. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company’s revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.60 earnings per share. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Stock Performance

NYSE SEM opened at $14.27 on Thursday. The firm’s fifty day moving average price is $12.99 and its two-hundred day moving average price is $14.32. The stock has a market cap of $1.77 billion, a PE ratio of 13.46, a PEG ratio of 0.56 and a beta of 1.28. Select Medical has a fifty-two week low of $11.65 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th were paid a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Wednesday, August 13th. Select Medical’s payout ratio is presently 23.58%.

Hedge Funds Weigh In On Select Medical

Several hedge funds and other institutional investors have recently bought and sold shares of the company. California State Teachers Retirement System lifted its holdings in Select Medical by 1.4% in the second quarter. California State Teachers Retirement System now owns 102,230 shares of the health services provider’s stock valued at $1,552,000 after buying an additional 1,418 shares during the period. Ameriprise Financial Inc. raised its holdings in shares of Select Medical by 0.7% during the second quarter. Ameriprise Financial Inc. now owns 304,632 shares of the health services provider’s stock valued at $4,624,000 after purchasing an additional 2,113 shares during the period. Orion Porfolio Solutions LLC raised its holdings in shares of Select Medical by 22.6% during the second quarter. Orion Porfolio Solutions LLC now owns 12,823 shares of the health services provider’s stock valued at $195,000 after purchasing an additional 2,368 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Select Medical by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,400 shares of the health services provider’s stock valued at $1,075,000 after purchasing an additional 2,809 shares during the period. Finally, Cerity Partners LLC raised its holdings in shares of Select Medical by 4.3% during the second quarter. Cerity Partners LLC now owns 97,877 shares of the health services provider’s stock valued at $1,486,000 after purchasing an additional 3,991 shares during the period. Institutional investors and hedge funds own 89.48% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on SEM shares. Bank of America cut their price target on shares of Select Medical from $18.00 to $15.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Royal Bank Of Canada lifted their price target on shares of Select Medical from $16.00 to $20.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Select Medical in a report on Wednesday, October 8th. Finally, UBS Group reiterated a “neutral” rating and set a $14.00 price target (down previously from $15.00) on shares of Select Medical in a report on Monday, August 4th. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $19.40.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.